ArticleData in brief2025
Whole genome sequence data of
Article in Data in brief, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The genome of Comamonas sediminis FS4_11, a bacterial strain with mycotoxin fumonisin B1 (FB1) transformation capability, was sequenced using Oxford Nanopore Technologies (ONT) and Illumina platforms. The final assembly generated a circular chromosome of 5,148,490 bp with a mean G+C content of 63.74%, representing a contiguous genomic structure. Genome annotation predicted 4565 protein-coding sequences (CDSs), 82 transfer RNAs (tRNAs), 18 ribosomal RNAs (rRNAs; 6 each of 5S, 16S, and 23S rRNA), 1 transfer-messenger RNA (tmRNA), and 8 pseudogenes and other non-coding RNAs. Functional annotation identified 939 potential virulence factors, two putative AdeF-related antibiotic resistance genes, 1486 potential pathogen-host interaction proteins, and a candidate carboxylesterase for FB1 transformation. This dataset primarily aids in identifying potential FB1 detoxification enzyme genes and assessing strain biosafety. It also offers significant reuse potential for comparative genomics and understanding bacterial evolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.